Not finding it? Sign in to also search OpenAlex live.
-
Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia
Peter A. von dem Borne, Tjeerd J.F. Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriëtte Levenga, +9 more
1citations -
Long-term outcome and risk factors for relapse after allogeneic hematopoietic stem cell transplantation in myelofibrosis: Results from a large multicenter cohort2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Julia-Annabell Georgi, Sebastian Stasik, Michael Krämer, Tobias A.W. Holderried, Jochen J. Frietsch, Stefan Klein, +18 more
0citations -
Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia: A Systematic Review and Meta-analysis2020 Schizophrenia Bulletin Open review Medicine Schizophrenia research and treatment Open access cited by 1 patent
Jan P.A.M. Bogers, George Hambarian, Maykel Michiels, Jentien M. Vermeulen, Lieuwe de Haan
33citations -
GSTM1 and GSTT1 Double Null Genotypes Determining Cell Fate and Proliferation as Potential Risk Factors of Relapse in Children with Hematological Malignancies after Stem Cell Transplantation.2021 Research Square preprint Biochemistry, Genetics and Molecular Biology Glutathione Transferases and Polymorphisms Open access
Simona Jurković Mlakar, Chakradhara Rao S. Uppugunduri, Tiago Nava, Vid Mlakar, Hadrien G. Golay, Shannon K. D. Robin, +11 more
1citations -
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation2021 Journal of Cancer Research and Clinical Oncology article Biochemistry, Genetics and Molecular Biology Glutathione Transferases and Polymorphisms Open access
Simona Jurković Mlakar, Chakradhara Rao S. Uppugunduri, Tiago Nava, Vid Mlakar, Hadrien G. Golay, Shannon K. D. Robin, +11 more
6citations -
Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn’s disease2022 European Journal of Gastroenterology & Hepatology article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Sebastiaan ten Bokkel Huinink, D C de Jong, Daan Nieboer, Doranne Thomassen, Ewout Willem Steyerberg, Marcel G. W. Dijkgraaf, +19 more
4citations -
T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS2020 Schizophrenia Bulletin conference-abstract Medicine Schizophrenia research and treatment Open access
Jan P.A.M. Bogers, George Hambarian, Jentien M. Vermeulen, Lieuwe de Haan
2citations -
GSTM1 and GSTT1 Double Null Genotypes Determining Cell Fate and Proliferation as Potential Risk Factors of Relapse in Children With Hematological Malignancies After Stem Cell Transplantation. On Behalf of the Pediatric Disease Working Party of the European Society for Blood and Marrow Transplantation2021 Research Square preprint Biochemistry, Genetics and Molecular Biology Glutathione Transferases and Polymorphisms Open access
Simona Jurković Mlakar, Chakradhara Rao S. Uppugunduri, Tiago Nava, Vid Mlakar, Hadrien G. Golay, Shannon K. D. Robin, +10 more
0citations -
Abstract OT1-02-01: Phase III postneoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment - SASCIA2022 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Frederik Marmé, Marcus Schmidt, Jenny Furlanetto, Carsten Denkert, Anthony Gonçalvès, Elmar Stickeler, +15 more
0citations -
Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation2021 Journal of Cancer Research and Clinical Oncology erratum Biochemistry, Genetics and Molecular Biology Glutathione Transferases and Polymorphisms Open access
Simona Jurković Mlakar, Tiago Nava, Vid Mlakar, Hadrien G. Golay, Shannon K. D. Robin, Nicolas Waespe, +10 more
1citations -
Real-Life Data of Cyclosporine (CsA) Tapering in Patients with Very/ Severe Aplastic Anemia (v/sAA) Treated with Horse Anti-Thymocyte Globulin (hATG/CsA) Suggest Higher Risk of AA Relapse at Cyclosporine Plasma Levels below 100 Nanogram per Milliliter2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments
Jeanette Walter, Kim Kricheldorf, Yannic Schumacher, Susanne Isfort, Jörg Chromik, Beatrice Drexler, +4 more
2citations -
POS0772 TOWARDS CLINICAL ENDOTYPING OF OLIGOARTICULAR AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS PATIENTS IN ADULTHOOD: RISK OF RELAPSE AND ASSOCIATED FACTORS2024 Annals of the Rheumatic Diseases conference-abstract Medicine Autoimmune and Inflammatory Disorders Research
Laura Scagnellato, Francesco Zulian, Andrea. Schwartz Doria, Roberta Ramonda, Ilaria Prosepe
0citations -
Phase III postneoadjuvant study evaluating sacituzumab govitecan, an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA.2021 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Frederik Marmé, Elmar Stickeler, Jenny Furlanetto, Carsten Denkert, Marcus Schmidt, Mattea Reinisch, +10 more
27citations -
Should the European Leukemia Net 2022 Adverse Risk Classification of NPM1 mutated Acute Myeloid Leukemia be Revisited? Among Adverse Risk Cytogenetics, Solely Complex Karyotype Is Associated with Worse Post-Transplant Survival: A Study from the EBMT Acute Leukemia Working Party
Nour M. Moukalled, Myriam Labopin, Jurjen Versluis, Gèrard Socié, Didier Blaise, Urpu Salmenniemi, +12 more
0citations -
Allogeneic Hematopoietic Cell Transplantation in Patients ≤ 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-
Martin Bornhaeuser, Christoph Schliemann, Johannes Schetelig, Christoph Röllig, Michael Krämer, Bertram Glaß, +21 more
2citations